Gemini Therapeutics (GMTX) Stock Chart & Stock Price History $58.97 -0.79 (-1.32%) As of 08/1/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrendsBuy This Stock Gemini Therapeutics Stock Price Performance The Gemini Therapeutics (GMTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 36.28%, with a year-to-date return of -4.27%. In the past month, the stock has increased 10.91%, reflecting recent market activity. As of the latest close, Gemini Therapeutics traded at $59.76 with a market cap of $2.59 billion and volume of 336,128 shares. Receive GMTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.39%1 Month Performance+10.91%3 Month Performance+18.70%Year-To-Date Performance-4.27%1 Year Performance+36.28% GMTX Stock Chart for Monday, August, 4, 2025 GMTX Chart by TradingView Gemini Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/04/2025$58.97$58.97$60.01$58.01373,398 shs$2.56 billion08/01/2025$59.35$59.76+0.69%$60.80$58.86336,128 shs$2.59 billion07/31/2025$59.80$59.35-0.75%$61.59$59.11377,185 shs$2.57 billion07/30/2025$59.48$59.80+0.54%$60.08$58.63196,572 shs$2.59 billion07/29/2025$60.61$59.48-1.86%$60.95$59.40298,411 shs$2.58 billion07/28/2025$60.61$60.61$60.83$59.47224,396 shs$2.63 billion07/25/2025$60.94$60.58-0.59%$61.73$59.52418,401 shs$2.62 billion07/24/2025$60.74$60.94+0.33%$61.28$59.80380,446 shs$2.64 billion07/23/2025$59.38$60.74+2.29%$60.83$58.56300,273 shs$2.63 billion07/22/2025$57.77$59.38+2.79%$59.85$57.42554,664 shs$2.57 billion Get the Latest News and Ratings for GMTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/21/2025$57.77$57.77$62.00$57.43672,319 shs$2.50 billion07/18/2025$57.34$57.79+0.78%$59.75$57.38613,868 shs$2.50 billion07/17/2025$56.27$57.34+1.90%$57.62$55.99422,820 shs$2.48 billion07/16/2025$57.74$56.27-2.55%$58.31$55.77205,018 shs$2.44 billion07/15/2025$56.91$57.74+1.46%$58.61$56.59235,086 shs$2.50 billion07/14/2025$56.91$56.91$57.73$56.22275,330 shs$2.47 billion07/11/2025$55.86$58.00+3.83%$58.03$54.73346,531 shs$2.51 billion07/10/2025$52.97$55.86+5.46%$56.41$53.38406,536 shs$2.42 billion07/09/2025$53.38$52.97-0.77%$54.56$52.81163,376 shs$2.30 billion07/08/2025$54.75$53.38-2.50%$54.60$52.70195,341 shs$2.31 billion07/07/2025$54.75$54.75$55.26$53.17218,300 shs$2.37 billion07/04/2025$53.17$54.75+2.97%$55.26$53.17218,300 shs$2.37 billion07/03/2025$51.13$53.17+3.99%$53.66$51.03503,663 shs$2.30 billion Related Companies Ascendis Pharma A/S Stock Price Chart BridgeBio Pharma Stock Price Chart Verona Pharma PLC American Depositary Share Stock Price Chart Blueprint Medicines Stock Price Chart Legend Biotech Stock Price Chart Roivant Sciences Stock Price Chart Regencell Bioscience Stock Price Chart Elanco Animal Health Stock Price Chart Revolution Medicines Stock Price Chart Grifols Stock Price Chart Receive GMTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GMTX) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gemini Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gemini Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GMTX Stock Alerts